Common Contracts
2 similar Warrant Exercise Agreement contracts by Citius Pharmaceuticals, Inc.
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • February 19th, 2020 • Citius Pharmaceuticals, Inc. • Pharmaceutical preparations
This Warrant Exercise Agreement (this “Agreement”), dated as of February 14, 2020, is by and between Citius Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and the undersigned holder (each, a “Holder” and, collectively, the “Holders”) of warrants to purchase shares of common stock of the Company, par value $0.001 per share (the “Common Stock”), at an exercise price of $0.77 per share, issued by the Company on September 27, 2019 in connection with its underwritten public Offering (the “September 2019 Warrants”) and warrants to purchase Common Stock, at an exercise price of $2.86 per share, issued by the Company on March 29, 2018 (the “March 2019 Warrants”, and together with the September 2019 Warrants, the “Original Warrants”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • February 19th, 2020 • Citius Pharmaceuticals, Inc. • Pharmaceutical preparations
This Warrant Exercise Agreement (this “Agreement”), dated as of February 14, 2020, is by and between Citius Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and the undersigned holder (each, a “Holder” and, collectively, the “Holders”) of warrants to purchase shares of common stock of the Company, par value $0.001 per share (the “Common Stock”), at an exercise price of $0.77 per share, issued by the Company on September 27, 2019 in connection with its underwritten public Offering (the “September 2019 Warrants”) and warrants to purchase Common Stock, at an exercise price of $1.42 per share, issued by the Company on April 3, 2019 (the “April 2019 Warrants”, and together with the September 2019 Warrants, the “Original Warrants”).
